Albert David Limited (NSE:ALBERTDAVD)

India · Delayed Price · Currency is INR

711.00

+5.20 (0.74%)

May 25, 2026, 12:00 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Manufacturing of Pharmaceutical Products	3.34B	3.46B	3.62B	3.42B	3.14B
Manufacturing of Pharmaceutical Products Growth	-3.52%	-4.61%	6.12%	8.95%	26.70%
Total	3.34B	3.46B	3.62B	3.42B	3.14B
Total Growth	-3.52%	-4.61%	6.12%	8.95%	26.70%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	3.20B	3.34B	3.24B	2.95B
India Growth	-4.27%	3.05%	10.08%	25.84%
Overseas	232.04M	259.57M	156.13M	177.30M
Overseas Growth	-10.61%	66.26%	-11.94%	39.54%
Total	3.43B	3.60B	3.40B	3.12B
Total Growth	-4.72%	5.96%	8.83%	26.55%

Source: S&P Global Market Intelligence.